Dafalgan and aspartate aminotransferase increased Patient Reports February 09, 2010
Dafalgan Side Effects Report #5070937-1
Dafalgan side effect was reported by a Consumer or non-health professional from FRANCE on July 28, 2006. Female patient, 68 years of age, was diagnosed with pyelonephritis and was treated with Dafalgan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatitis
, hyperbilirubinaemia. Dafalgan dosage: unknown. During the same period patient was treated with OFLOCET, BISOPROLOL FUMARATE, RIFADIN, AMLODIPINE BESYLATE, TAREG. Patient was hospitalized. Patient recovered.Dafalgan Side Effects Report #5117233-1
Dafalgan side effect was reported by a Consumer or non-health professional from FRANCE on July 28, 2006. Female patient, 68 years of age, weighting 207.2 lb, was diagnosed with pyelonephritis and was treated with Dafalgan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, hepatitis
, hyperbilirubinaemia, jaundice
. Dafalgan dosage: unknown. During the same period patient was treated with OFLOCET, BISOPROLOL FUMARATE, RIFADIN, AMLOR, TAREG, ORACEFAL. Patient was hospitalized. Patient recovered.Dafalgan Side Effects Report #4752206-X
Dafalgan side effect was reported by a Consumer or non-health professional from FRANCE on Mar 22, 2005. Female patient, 52 years of age, was treated with Dafalgan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatitis
. Dafalgan dosage: 500 MG, 6QD. During the same period patient was treated with FRAXIPARINE, DUPHALAC, LIORESAL, PERFALGAN. Patient was hospitalized. Patient recovered.
Dafalgan and aspartate aminotransferase increased 